Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Sell
48
SRPT Quote, Financials, Valuation and Earnings
Last price:
$74.08
Seasonality move
:
14.66%
Day range:
$73.05 - $75.50
52-week range:
$73.05 - $173.25
Dividend yield:
0%
P/E ratio:
32.50x
P/S ratio:
4.35x
P/B ratio:
4.71x
Volume:
2.6M
Avg. volume:
1.7M
1-year change:
-40.69%
Market cap:
$7.2B
Revenue:
$1.9B
EPS (TTM):
$2.28
Sarepta Therapeutics Number of Institutional Trades
Sarepta Therapeutics Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$16.2B
(Last 6 Months)
Current Institutional Ownership Percentage
--
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$21.4B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Sarepta Therapeutics Institutional Ownership
-
What Percentage Of SRPT Is Owned by Institutions?
-- of SRPT is owned by institutions.
-
How Many Institutions Own SRPT Shares?
Sarepta Therapeutics stock is owned by 1,015 institutional shareholders at this time.
-
Have Institutions Been Buying SRPT Stock?
Yes, institutions have bought 68.4M shares of SRPT in the last quarter.
-
Have Institutions Been Selling SRPT Stock?
Yes, institutions have sold 96M shares of SRPT over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
